Severe chronic active Epstein-Barr virus infection syndrome

Motohiko Okano, Shuzo Matsumoto, Toyoro Osato, Yukio Sakiyama, Geoffrey Milton Thiele, David T. Purtilo

Research output: Contribution to journalReview article

140 Citations (Scopus)

Abstract

Reports of unusually severe lymphoproliferative disorders associated with extremely high antibody titers against Epstein-Barr virus (EBV) have recently increased. The syndrome, which we designated severe chronic active EBV infection syndrome, is characterized by persistent or intermittent fever, lymphadenopathy, and hepatosplenomegaly and primarily affects children and young adults. Polyclonal gammopathy and bone marrow suppression are generally observed, and some patients develop B-cell or T-cell lymphoproliferation or lymphoma. Frequently, EBV genomes are detectable in tissues infiltrated with lymphoid cells. Additionally, it is difficult to establish spontaneous or B95-8 EBV-induced cell lines despite the expression of an activated EBV infection. We review and report here the published medical literature and our own experience regarding patients with severe chronic active EBV infection syndrome in an attempt to understand this enigmatic syndrome and the possible pathogenetic mechanism(s) responsible for this disorder.

Original languageEnglish (US)
Pages (from-to)129-135
Number of pages7
JournalClinical Microbiology Reviews
Volume4
Issue number1
DOIs
StatePublished - Jan 1 1991

Fingerprint

Epstein-Barr Virus Infections
Human Herpesvirus 4
Lymphoproliferative Disorders
Young Adult
Lymphoma
B-Lymphocytes
Fever
Bone Marrow
Genome
Lymphocytes
T-Lymphocytes
Cell Line
Antibodies

ASJC Scopus subject areas

  • Epidemiology
  • Immunology and Microbiology(all)
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Okano, M., Matsumoto, S., Osato, T., Sakiyama, Y., Thiele, G. M., & Purtilo, D. T. (1991). Severe chronic active Epstein-Barr virus infection syndrome. Clinical Microbiology Reviews, 4(1), 129-135. https://doi.org/10.1128/CMR.4.1.129

Severe chronic active Epstein-Barr virus infection syndrome. / Okano, Motohiko; Matsumoto, Shuzo; Osato, Toyoro; Sakiyama, Yukio; Thiele, Geoffrey Milton; Purtilo, David T.

In: Clinical Microbiology Reviews, Vol. 4, No. 1, 01.01.1991, p. 129-135.

Research output: Contribution to journalReview article

Okano, M, Matsumoto, S, Osato, T, Sakiyama, Y, Thiele, GM & Purtilo, DT 1991, 'Severe chronic active Epstein-Barr virus infection syndrome', Clinical Microbiology Reviews, vol. 4, no. 1, pp. 129-135. https://doi.org/10.1128/CMR.4.1.129
Okano, Motohiko ; Matsumoto, Shuzo ; Osato, Toyoro ; Sakiyama, Yukio ; Thiele, Geoffrey Milton ; Purtilo, David T. / Severe chronic active Epstein-Barr virus infection syndrome. In: Clinical Microbiology Reviews. 1991 ; Vol. 4, No. 1. pp. 129-135.
@article{faf3b01c9d924b4f9e5eaf0188642e64,
title = "Severe chronic active Epstein-Barr virus infection syndrome",
abstract = "Reports of unusually severe lymphoproliferative disorders associated with extremely high antibody titers against Epstein-Barr virus (EBV) have recently increased. The syndrome, which we designated severe chronic active EBV infection syndrome, is characterized by persistent or intermittent fever, lymphadenopathy, and hepatosplenomegaly and primarily affects children and young adults. Polyclonal gammopathy and bone marrow suppression are generally observed, and some patients develop B-cell or T-cell lymphoproliferation or lymphoma. Frequently, EBV genomes are detectable in tissues infiltrated with lymphoid cells. Additionally, it is difficult to establish spontaneous or B95-8 EBV-induced cell lines despite the expression of an activated EBV infection. We review and report here the published medical literature and our own experience regarding patients with severe chronic active EBV infection syndrome in an attempt to understand this enigmatic syndrome and the possible pathogenetic mechanism(s) responsible for this disorder.",
author = "Motohiko Okano and Shuzo Matsumoto and Toyoro Osato and Yukio Sakiyama and Thiele, {Geoffrey Milton} and Purtilo, {David T.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1128/CMR.4.1.129",
language = "English (US)",
volume = "4",
pages = "129--135",
journal = "Clinical Microbiology Reviews",
issn = "0893-8512",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Severe chronic active Epstein-Barr virus infection syndrome

AU - Okano, Motohiko

AU - Matsumoto, Shuzo

AU - Osato, Toyoro

AU - Sakiyama, Yukio

AU - Thiele, Geoffrey Milton

AU - Purtilo, David T.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Reports of unusually severe lymphoproliferative disorders associated with extremely high antibody titers against Epstein-Barr virus (EBV) have recently increased. The syndrome, which we designated severe chronic active EBV infection syndrome, is characterized by persistent or intermittent fever, lymphadenopathy, and hepatosplenomegaly and primarily affects children and young adults. Polyclonal gammopathy and bone marrow suppression are generally observed, and some patients develop B-cell or T-cell lymphoproliferation or lymphoma. Frequently, EBV genomes are detectable in tissues infiltrated with lymphoid cells. Additionally, it is difficult to establish spontaneous or B95-8 EBV-induced cell lines despite the expression of an activated EBV infection. We review and report here the published medical literature and our own experience regarding patients with severe chronic active EBV infection syndrome in an attempt to understand this enigmatic syndrome and the possible pathogenetic mechanism(s) responsible for this disorder.

AB - Reports of unusually severe lymphoproliferative disorders associated with extremely high antibody titers against Epstein-Barr virus (EBV) have recently increased. The syndrome, which we designated severe chronic active EBV infection syndrome, is characterized by persistent or intermittent fever, lymphadenopathy, and hepatosplenomegaly and primarily affects children and young adults. Polyclonal gammopathy and bone marrow suppression are generally observed, and some patients develop B-cell or T-cell lymphoproliferation or lymphoma. Frequently, EBV genomes are detectable in tissues infiltrated with lymphoid cells. Additionally, it is difficult to establish spontaneous or B95-8 EBV-induced cell lines despite the expression of an activated EBV infection. We review and report here the published medical literature and our own experience regarding patients with severe chronic active EBV infection syndrome in an attempt to understand this enigmatic syndrome and the possible pathogenetic mechanism(s) responsible for this disorder.

UR - http://www.scopus.com/inward/record.url?scp=0025967022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025967022&partnerID=8YFLogxK

U2 - 10.1128/CMR.4.1.129

DO - 10.1128/CMR.4.1.129

M3 - Review article

C2 - 1848476

AN - SCOPUS:0025967022

VL - 4

SP - 129

EP - 135

JO - Clinical Microbiology Reviews

JF - Clinical Microbiology Reviews

SN - 0893-8512

IS - 1

ER -